Dear readers,
In February 2025, the FDA made a quiet but monumental decision that will change the landscape of men’s health: removing language from the Boxed Warning related to an increased risk of adverse cardiovascular outcomes for all testosterone products. This landmark change represents the culmination of over a decade of scientific research and marks a turning point for testosterone replacement therapy (TRT).
As a physician who has witnessed firsthand how the black box warning has prevented countless men from accessing potentially life-changing treatment, I want to help you understand what this means and why it matters.
The Journey to This Moment
The controversy began in 2014 when the FDA issued warnings about potential cardiovascular risks with testosterone therapy. FDA first convened a Joint Meeting of the Bone, Reproductive and Urologic Drugs and the Drug Safety and Risk Management Advisory Committee in September 2014 following increased reports of stroke, heart attack, and death in men taking FDA-approved testosterone products.
By 2015, the FDA required all testosterone product manufacturers to add a black box warning about possible increased risk of heart attacks and strokes in patients taking testosterone. This warning was based on limited, often flawed observational studies that showed conflicting results. The decision created a chilling effect on testosterone prescribing, leaving millions of men with legitimate medical needs without access to treatment.
This black box warning – the FDA’s most serious safety alert – was based on limited, often flawed observational studies that showed conflicting results. The decision created a chilling effect on testosterone prescribing, leaving millions of men with legitimate medical needs without access to treatment.
The TRAVERSE Trial: Science Over Fear
The FDA’s recent decision is based primarily on the results of the TRAVERSE (Testosterone Replacement Therapy for Assessment of Long-term Vascular Events and Efficacy Response in Hypogonadal Men) trial, a multicenter, randomized, double-blind, placebo-controlled, noninferiority, event-driven trial that was specifically mandated by the FDA to address cardiovascular safety concerns.
Study Design and Participants
The TRAVERSE trial was impressive in both scope and rigor. We enrolled 5246 men 45 to 80 years of age who had preexisting or a high risk of cardiovascular disease and documented hypogonadism. These weren’t healthy young men looking for a performance boost – these were men with genuine medical conditions who could benefit from testosterone therapy.
Importantly, all participants also had to have two fasting serum testosterone results below 300 ng/dL from morning blood draws separated by at least 48 hours. “These are men with documented mild to moderate hypogonadism,” Dr. Lincoff notes.
The study followed men for a mean 27.1 months, with participants receiving either testosterone gel or placebo, carefully titrated to maintain testosterone levels in the normal range.
The Results That Changed Everything
The primary finding was clear and decisive: In men with hypogonadism and preexisting or a high risk of cardiovascular disease, testosterone-replacement therapy was noninferior to placebo with respect to the incidence of major adverse cardiac events.
To put this in perspective, the 372 confirmed cardiovascular events observed in this trial were more than all prior randomized trials of testosterone combined. “This is the most definitive answer to this research question we are likely to get,” noted the study’s lead investigator.
The trial showed no increased risk of:
- Heart attacks
- Strokes
- Cardiovascular deaths
- Overall mortality
The Health Benefits of Testosterone Optimization
The TRAVERSE trial revealed several important benefits of testosterone therapy, including a 22.5% reduction in new-onset diabetes, improvements in sexual desire and activity, reduced depression, and correction of anemia. But the benefits of testosterone optimization extend far beyond what was measured in this study.
When we optimize testosterone levels to the upper third of the normal range (typically 700-1000 ng/dL), men frequently experience:
Metabolic Benefits:
- Improved insulin sensitivity and glucose metabolism
- Increased lean muscle mass and reduced body fat
- Enhanced metabolic rate and weight management
- Better cholesterol profiles
Physical Performance:
- Increased energy and endurance
- Improved exercise capacity and recovery
- Enhanced bone density and strength
- Better sleep quality and recovery
Cognitive and Emotional Benefits:
- Sharper mental clarity and focus
- Improved mood and reduced anxiety
- Enhanced motivation and drive
- Better stress resilience
Sexual Health:
- Improved libido and sexual function
- Enhanced overall sexual satisfaction
- Better relationship quality
Cardiovascular Health: The evidence now suggests that optimizing testosterone may actually be protective for heart health, with studies showing that men with higher testosterone levels have lower rates of cardiovascular disease and mortality.
What This Means for Patients
For years, “patients have been unduly apprehensive about testosterone replacement therapy due to the Black Box Warning, leading many to avoid a treatment that could significantly improve their health,” said Shalin Shah, CEO of Marius Pharmaceuticals.
The removal of this warning represents more than just a regulatory change – it’s a return to evidence-based medicine. The strength of these studies, combined with today’s FDA decision, shifts the conversation from “Is testosterone safe?” to “What are the full health benefits testosterone can provide?”
Important Context and Our Approach
However, it’s crucial to understand what this change does and doesn’t mean. The cardiovascular safety findings apply specifically to men with documented hypogonadism who received careful medical supervision and monitoring.
At The Gajer Practice, we believe that men with suboptimal testosterone levels – not just those with severely low levels – can benefit significantly from testosterone optimization. Our approach goes beyond simply treating “low T” to optimizing testosterone levels into the upper third of the normal range, where men typically experience the most significant improvements in energy, mood, body composition, and overall vitality.
The study specifically enrolled men with documented testosterone deficiency, but we recognize that optimal health occurs when testosterone levels are not just “normal” but optimized for peak performance and well-being.
New Safety Considerations
While the cardiovascular black box warning has been removed, the FDA has added new guidance based on blood pressure monitoring studies. The updated labeling now includes information about potential increases in blood pressure with testosterone therapy.
This means that while we now know testosterone doesn’t increase cardiovascular events, we monitor blood pressure carefully during treatment as part of our comprehensive approach to testosterone optimization.
The Broader Implications
This FDA decision represents a validation of what many clinicians have observed in practice: when testosterone therapy is used appropriately in men with genuine hypogonadism, under proper medical supervision, the benefits far outweigh the risks.
A global consensus has emerged on testosterone’s cardiovascular profile, supported by robust studies. Notably, an 83,000-patient study from the Veterans Affairs (VA) system concluded that men receiving TRT experienced cardiovascular benefits.
The evidence now suggests that rather than causing cardiovascular problems, low testosterone itself may be the real risk factor. Men with low testosterone have higher rates of diabetes, cardiovascular disease, depression, and overall mortality.
Moving Forward: Testosterone Optimization at The Gajer Practice
At The Gajer Practice, this FDA decision validates the careful, evidence-based approach we’ve always taken to testosterone optimization. We’ve continued to help men achieve optimal testosterone levels throughout the controversy because the science supported it, but now we can do so without the cloud of regulatory uncertainty.
Our approach to testosterone optimization includes:
Comprehensive Assessment: We evaluate not just testosterone levels but overall health, symptoms, and quality of life markers to determine if optimization is appropriate.
Personalized Protocols: Rather than one-size-fits-all dosing, we customize treatment to achieve optimal levels in the upper third of the normal range for each individual.
Multiple Delivery Options: We offer various testosterone delivery methods including injections (in-office or self-administered) and topical preparations to match your lifestyle and preferences.
Ongoing Monitoring: Regular follow-up with laboratory testing, symptom assessment, and health optimization to ensure both safety and effectiveness.
Holistic Approach: We address testosterone optimization as part of comprehensive health optimization, including nutrition, exercise, sleep, and stress management.
The Bottom Line
The removal of the black box warning doesn’t mean testosterone is appropriate for everyone, but it does mean we can now base our treatment decisions on solid scientific evidence rather than regulatory fear.
For men with suboptimal testosterone who have been avoiding treatment due to cardiovascular concerns, this represents a new opportunity to reclaim their health and vitality. For those already on therapy, it provides reassurance that their treatment choice is supported by the highest level of scientific evidence.
At The Gajer Practice, we believe that optimization – not just replacement – is the key to helping men achieve their best possible health and performance. The goal isn’t simply to get testosterone levels into the “normal” range, but to optimize them for peak function and vitality.
As we move into this new era of testosterone therapy, the focus can finally shift from “Is it safe?” to “How can we optimize testosterone levels to help men live their healthiest, most vital lives?”
The science has spoken, and it’s clear: when used appropriately under proper medical supervision, testosterone optimization is both safe and profoundly beneficial for men who need it.
If you’ve been considering testosterone optimization or have questions about your current treatment, this is an excellent time to schedule a comprehensive evaluation. Contact The Gajer Practice +1-703-866-4144 to discuss whether testosterone optimization might be right for you.
CLICK HERE TO SCHEDULE YOUR FREE HORMONE AND PERFORMANCE CONSULTATION
To your health,
Dr. Aleksandra Gajer
